Roche Holding AG Market Cap 2006-2019 | RHHBY

Roche Holding AG market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Roche Holding AG market cap as of February 20, 2020 is $300.37B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $300.375B $61.869B
Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.914B 17.09
Novartis AG (NVS) Switzerland $220.677B 18.38
Merck (MRK) United States $210.018B 15.89
Pfizer (PFE) United States $198.398B 12.15
Novo Nordisk (NVO) Denmark $150.392B 25.82
AbbVie (ABBV) United States $139.349B 10.54
Eli Lilly (LLY) United States $135.806B 23.51
AstraZeneca (AZN) United Kingdom $128.407B 27.65
Sanofi (SNY) France $127.085B 15.10
GlaxoSmithKline (GSK) United Kingdom $106.698B 13.53
Bristol-Myers Squibb (BMY) United States $106.180B 13.95
Bayer (BAYRY) Germany $75.462B 11.18
H Lundbeck (HLUYY) Denmark $7.744B 13.45